[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$fEb4D19p_Mr0FTi7mx6aYb8FrrPvcCzVJgO8JBe3hkzU":3},{"sponsor":4,"sponsorVariants":5,"totalTrials":6,"truncated":7,"activeTrials":8,"phase3Count":9,"totalEnrollment":10,"activePrograms":11,"nonDrugCount":12,"topConditions":13,"upcomingReadouts":35,"phaseBuckets":86,"rows":93},"Medical University of Warsaw",[4],310,false,67,11,78663,21,240,[14,17,20,23,26,29,31,33],{"name":15,"count":16},"Heart Failure",14,{"name":18,"count":19},"Food Allergy",8,{"name":21,"count":22},"Obesity",7,{"name":24,"count":25},"Knee Osteoarthritis",6,{"name":27,"count":28},"Atrial Fibrillation",5,{"name":30,"count":28},"Liver Cirrhosis",{"name":32,"count":28},"Children",{"name":34,"count":28},"Diarrhea",[36,41,46,51,56,61,66,71,76,81],{"nctId":37,"briefTitle":38,"date":39,"intervention":40},"NCT05804591","Pregabalin in the Obese Patients Undergoing Laparoscopic Sleeve Gastrectomy (LSG).","2025-04-01","Pregabalin 150mg",{"nctId":42,"briefTitle":43,"date":44,"intervention":45},"NCT05527704","the Inhaled β2-adrenergic Receptor Agonist for Transient Tachypnoea of the Newborn (the REFSAL Trial)","2025-11-30","Salbutamol",{"nctId":47,"briefTitle":48,"date":49,"intervention":50},"NCT06328504","Efficacy of Cashew Nut Protein Immunotherapy","2026-04-21","Cashew immunotherapy",{"nctId":52,"briefTitle":53,"date":54,"intervention":55},"NCT06555237","MEK Inhibitors for the Treatment of Hypertrophic Cardiomyopathy in Patients With RASopathies","2026-08-01","Trametinib",{"nctId":57,"briefTitle":58,"date":59,"intervention":60},"NCT06843122","Evaluation of the Safety and Efficacy of Live ASCs in the Treatment of Diabetic Foot (FOOTCELL)","2027-02-28","A - Allogenic ADSC cells in fibrin solution - two times administration ADSC\u002FASC",{"nctId":62,"briefTitle":63,"date":64,"intervention":65},"NCT07012889","Intraoperative Continuous Lidocaine Infusion in Laparoscopic Liver Surgery","2027-03-02","lidocaine",{"nctId":67,"briefTitle":68,"date":69,"intervention":70},"NCT07120490","STOP-CDI: Efficacy of Fecal Microbiota Transplantation vs Fidaxomicin vs Vancomycin in Treating and Preventing Relapse of Clostridioides Difficile Infection","2027-03-31","Fidaxomicin",{"nctId":72,"briefTitle":73,"date":74,"intervention":75},"NCT07024199","Comparison of the Effectiveness of Paracetamol With Ibuprofen or Paracetamol With Metamizole in Treating Pain in Acute Pancreatitis in Children","2027-06-01","Drug administration according to protocol",{"nctId":77,"briefTitle":78,"date":79,"intervention":80},"NCT06563349","Magnesium Sulfate in Children Undergoing Laparoscopic Appendectomy","2027-09-01","Intravenous magnesium sulfate",{"nctId":82,"briefTitle":83,"date":84,"intervention":85},"NCT04654988","Study to Evaluate the Efficacy of Immunosuppression in Myocarditis or Inflammatory Cardiomyopathy.","2027-09-30","Prednisone",[87,88,89,90,91,92],"EARLY_PHASE1","PHASE1","PHASE2","PHASE3","PHASE4","NA",[94,137,164,188,206,236,254,279,297,323,341,367,385,409,427,451,469,502,523,550,568,594,669,703,734,771,800,825,852,870,895,918,949,975,993,1032,1050,1082,1100,1118,1136,1154,1172,1197,1222,1248,1266,1284,1309,1327,1353,1378,1402,1420,1444,1467,1491,1515,1543,1571,1589,1607,1634,1652,1679,1697,1721,1745,1773,1797,1822,1849,1873,1896,1922,1940,1964,1990,2026,2060,2082,2110,2135,2160,2178,2204,2233,2255,2281,2309,2338],{"intervention":95,"totalTrials":96,"cells":97},"Normal saline",2,{"EARLY_PHASE1":98,"PHASE1":101,"PHASE2":103,"PHASE3":105,"PHASE4":107,"NA":135},{"trials":99,"activeCount":100},[],0,{"trials":102,"activeCount":100},[],{"trials":104,"activeCount":100},[],{"trials":106,"activeCount":100},[],{"trials":108,"activeCount":134,"soonestReadout":79},[109,121],{"nctId":77,"briefTitle":78,"status":110,"phases":111,"primaryCompletion":79,"completion":112,"start":113,"enrollment":114,"conditions":115,"interventions":120},"RECRUITING",[91],"2027-10-01","2024-09-09",188,[116,117,118,119],"Opioid Consumption","Multimodal Analgesia","Acute Appendicitis","Complication of Treatment",[80,95],{"nctId":122,"briefTitle":123,"status":124,"phases":125,"primaryCompletion":126,"completion":126,"start":127,"enrollment":128,"conditions":129,"interventions":132},"NCT05238506","Lidocaine VS Hemodynamic, Metabolic and Hormonal Response","COMPLETED",[91],"2023-08-08","2022-03-12",132,[130,118,119,116,131],"Hemodynamic Response","Pneumoperitoneum",[133,95],"Intravenous lidocaine",1,{"trials":136,"activeCount":100},[],{"intervention":75,"totalTrials":134,"cells":138},{"EARLY_PHASE1":139,"PHASE1":141,"PHASE2":143,"PHASE3":145,"PHASE4":147,"NA":162},{"trials":140,"activeCount":100},[],{"trials":142,"activeCount":100},[],{"trials":144,"activeCount":100},[],{"trials":146,"activeCount":100},[],{"trials":148,"activeCount":134,"soonestReadout":74},[149],{"nctId":72,"briefTitle":73,"status":110,"phases":150,"primaryCompletion":74,"completion":74,"start":151,"enrollment":152,"conditions":153,"interventions":161},[91],"2025-09",78,[154,155,156,157,158,159,160],"Pancreatitis, Acute","Pain, Acute","Pancreatic Disease","Pancreatic Diseases","Gastroenterology","Pancreatitis","Paediatrics",[75],{"trials":163,"activeCount":100},[],{"intervention":40,"totalTrials":134,"cells":165},{"EARLY_PHASE1":166,"PHASE1":168,"PHASE2":170,"PHASE3":172,"PHASE4":174,"NA":186},{"trials":167,"activeCount":100},[],{"trials":169,"activeCount":100},[],{"trials":171,"activeCount":100},[],{"trials":173,"activeCount":100},[],{"trials":175,"activeCount":134,"soonestReadout":39},[176],{"nctId":37,"briefTitle":38,"status":110,"phases":177,"primaryCompletion":39,"completion":178,"start":179,"enrollment":180,"conditions":181,"interventions":185},[91],"2025-08-01","2023-04-24",90,[21,182,183,184],"Postoperative Pain","Postoperative Nausea and Vomiting","Opioid Use",[40],{"trials":187,"activeCount":100},[],{"intervention":80,"totalTrials":134,"cells":189},{"EARLY_PHASE1":190,"PHASE1":192,"PHASE2":194,"PHASE3":196,"PHASE4":198,"NA":204},{"trials":191,"activeCount":100},[],{"trials":193,"activeCount":100},[],{"trials":195,"activeCount":100},[],{"trials":197,"activeCount":100},[],{"trials":199,"activeCount":134,"soonestReadout":79},[200],{"nctId":77,"briefTitle":78,"status":110,"phases":201,"primaryCompletion":79,"completion":112,"start":113,"enrollment":114,"conditions":202,"interventions":203},[91],[116,117,118,119],[80,95],{"trials":205,"activeCount":100},[],{"intervention":207,"totalTrials":134,"cells":208},"lixisenatide + glargine",{"EARLY_PHASE1":209,"PHASE1":211,"PHASE2":213,"PHASE3":215,"PHASE4":217,"NA":234},{"trials":210,"activeCount":100},[],{"trials":212,"activeCount":100},[],{"trials":214,"activeCount":100},[],{"trials":216,"activeCount":100},[],{"trials":218,"activeCount":134,"soonestReadout":224},[219],{"nctId":220,"briefTitle":221,"status":222,"phases":223,"primaryCompletion":224,"completion":225,"start":226,"enrollment":227,"conditions":228,"interventions":232},"NCT07117240","Evaluation of the Efficacy and Safety of GLP-1 Receptor Agonist Therapy In Steroid-Induced Diabetes","ENROLLING_BY_INVITATION",[91],"2028-02-09","2028-07-10","2025-07-10",100,[229,230,231],"Steroid-Induced Diabetes","Steroid-Induced Hyperglycemia","Diabetes",[207,233],"Intensive insulin therapy",{"trials":235,"activeCount":100},[],{"intervention":233,"totalTrials":134,"cells":237},{"EARLY_PHASE1":238,"PHASE1":240,"PHASE2":242,"PHASE3":244,"PHASE4":246,"NA":252},{"trials":239,"activeCount":100},[],{"trials":241,"activeCount":100},[],{"trials":243,"activeCount":100},[],{"trials":245,"activeCount":100},[],{"trials":247,"activeCount":134,"soonestReadout":224},[248],{"nctId":220,"briefTitle":221,"status":222,"phases":249,"primaryCompletion":224,"completion":225,"start":226,"enrollment":227,"conditions":250,"interventions":251},[91],[229,230,231],[207,233],{"trials":253,"activeCount":100},[],{"intervention":85,"totalTrials":134,"cells":255},{"EARLY_PHASE1":256,"PHASE1":258,"PHASE2":260,"PHASE3":262,"PHASE4":264,"NA":277},{"trials":257,"activeCount":100},[],{"trials":259,"activeCount":100},[],{"trials":261,"activeCount":100},[],{"trials":263,"activeCount":100},[],{"trials":265,"activeCount":134,"soonestReadout":84},[266],{"nctId":82,"briefTitle":83,"status":110,"phases":267,"primaryCompletion":84,"completion":268,"start":269,"enrollment":227,"conditions":270,"interventions":275},[91],"2028-03-30","2022-12-01",[271,15,272,273,274],"Myocarditis","Endomyocardial Biopsy","Cardiomyopathies, Secondary","Immunosuppression",[85,276],"Azathioprine",{"trials":278,"activeCount":100},[],{"intervention":276,"totalTrials":134,"cells":280},{"EARLY_PHASE1":281,"PHASE1":283,"PHASE2":285,"PHASE3":287,"PHASE4":289,"NA":295},{"trials":282,"activeCount":100},[],{"trials":284,"activeCount":100},[],{"trials":286,"activeCount":100},[],{"trials":288,"activeCount":100},[],{"trials":290,"activeCount":134,"soonestReadout":84},[291],{"nctId":82,"briefTitle":83,"status":110,"phases":292,"primaryCompletion":84,"completion":268,"start":269,"enrollment":227,"conditions":293,"interventions":294},[91],[271,15,272,273,274],[85,276],{"trials":296,"activeCount":100},[],{"intervention":45,"totalTrials":134,"cells":298},{"EARLY_PHASE1":299,"PHASE1":301,"PHASE2":303,"PHASE3":305,"PHASE4":319,"NA":321},{"trials":300,"activeCount":100},[],{"trials":302,"activeCount":100},[],{"trials":304,"activeCount":100},[],{"trials":306,"activeCount":134,"soonestReadout":44},[307],{"nctId":42,"briefTitle":43,"status":308,"phases":309,"primaryCompletion":44,"completion":310,"start":311,"enrollment":312,"conditions":313,"interventions":317},"ACTIVE_NOT_RECRUITING",[90],"2026-09-30","2021-12-31",608,[314,315,316],"TTN","Respiratory Failure","PPHN",[45,318],"0,9% Chloride Sodium",{"trials":320,"activeCount":100},[],{"trials":322,"activeCount":100},[],{"intervention":318,"totalTrials":134,"cells":324},{"EARLY_PHASE1":325,"PHASE1":327,"PHASE2":329,"PHASE3":331,"PHASE4":337,"NA":339},{"trials":326,"activeCount":100},[],{"trials":328,"activeCount":100},[],{"trials":330,"activeCount":100},[],{"trials":332,"activeCount":134,"soonestReadout":44},[333],{"nctId":42,"briefTitle":43,"status":308,"phases":334,"primaryCompletion":44,"completion":310,"start":311,"enrollment":312,"conditions":335,"interventions":336},[90],[314,315,316],[45,318],{"trials":338,"activeCount":100},[],{"trials":340,"activeCount":100},[],{"intervention":342,"totalTrials":134,"cells":343},"budesonide",{"EARLY_PHASE1":344,"PHASE1":346,"PHASE2":348,"PHASE3":350,"PHASE4":363,"NA":365},{"trials":345,"activeCount":100},[],{"trials":347,"activeCount":100},[],{"trials":349,"activeCount":100},[],{"trials":351,"activeCount":134,"soonestReadout":356},[352],{"nctId":353,"briefTitle":354,"status":222,"phases":355,"primaryCompletion":356,"completion":356,"start":357,"enrollment":358,"conditions":359,"interventions":361},"NCT06719622","Evaluation of the Efficacy of Local Budesonide Treatment in Children with Crohn's Disease Located in the Esophagus And\u002For Stomach And\u002For Duodenum",[89,90],"2027-12-31","2024-07-30",114,[360],"Crohn Disease (CD)",[342,362],"omeprazole",{"trials":364,"activeCount":100},[],{"trials":366,"activeCount":100},[],{"intervention":362,"totalTrials":134,"cells":368},{"EARLY_PHASE1":369,"PHASE1":371,"PHASE2":373,"PHASE3":375,"PHASE4":381,"NA":383},{"trials":370,"activeCount":100},[],{"trials":372,"activeCount":100},[],{"trials":374,"activeCount":100},[],{"trials":376,"activeCount":134,"soonestReadout":356},[377],{"nctId":353,"briefTitle":354,"status":222,"phases":378,"primaryCompletion":356,"completion":356,"start":357,"enrollment":358,"conditions":379,"interventions":380},[89,90],[360],[342,362],{"trials":382,"activeCount":100},[],{"trials":384,"activeCount":100},[],{"intervention":60,"totalTrials":134,"cells":386},{"EARLY_PHASE1":387,"PHASE1":389,"PHASE2":391,"PHASE3":403,"PHASE4":405,"NA":407},{"trials":388,"activeCount":100},[],{"trials":390,"activeCount":100},[],{"trials":392,"activeCount":134,"soonestReadout":59},[393],{"nctId":57,"briefTitle":58,"status":394,"phases":395,"primaryCompletion":59,"completion":396,"start":397,"enrollment":398,"conditions":399,"interventions":401},"NOT_YET_RECRUITING",[89],"2027-08-01","2025-03-08",105,[400],"Diabetic Foot Ulcer",[60,402],"B - Allogenic ADSC cells in fibrin solution - one time administration of ADSC\u002FASC, one time of placebo",{"trials":404,"activeCount":100},[],{"trials":406,"activeCount":100},[],{"trials":408,"activeCount":100},[],{"intervention":402,"totalTrials":134,"cells":410},{"EARLY_PHASE1":411,"PHASE1":413,"PHASE2":415,"PHASE3":421,"PHASE4":423,"NA":425},{"trials":412,"activeCount":100},[],{"trials":414,"activeCount":100},[],{"trials":416,"activeCount":134,"soonestReadout":59},[417],{"nctId":57,"briefTitle":58,"status":394,"phases":418,"primaryCompletion":59,"completion":396,"start":397,"enrollment":398,"conditions":419,"interventions":420},[89],[400],[60,402],{"trials":422,"activeCount":100},[],{"trials":424,"activeCount":100},[],{"trials":426,"activeCount":100},[],{"intervention":55,"totalTrials":134,"cells":428},{"EARLY_PHASE1":429,"PHASE1":431,"PHASE2":433,"PHASE3":445,"PHASE4":447,"NA":449},{"trials":430,"activeCount":100},[],{"trials":432,"activeCount":100},[],{"trials":434,"activeCount":134,"soonestReadout":54},[435],{"nctId":52,"briefTitle":53,"status":110,"phases":436,"primaryCompletion":54,"completion":437,"start":438,"enrollment":439,"conditions":440,"interventions":443},[89],"2026-12-01","2024-08-01",40,[441,442],"Cardiomegaly","Noonan Syndrome",[55,444],"Standard therapy",{"trials":446,"activeCount":100},[],{"trials":448,"activeCount":100},[],{"trials":450,"activeCount":100},[],{"intervention":444,"totalTrials":134,"cells":452},{"EARLY_PHASE1":453,"PHASE1":455,"PHASE2":457,"PHASE3":463,"PHASE4":465,"NA":467},{"trials":454,"activeCount":100},[],{"trials":456,"activeCount":100},[],{"trials":458,"activeCount":134,"soonestReadout":54},[459],{"nctId":52,"briefTitle":53,"status":110,"phases":460,"primaryCompletion":54,"completion":437,"start":438,"enrollment":439,"conditions":461,"interventions":462},[89],[441,442],[55,444],{"trials":464,"activeCount":100},[],{"trials":466,"activeCount":100},[],{"trials":468,"activeCount":100},[],{"intervention":65,"totalTrials":96,"cells":470},{"EARLY_PHASE1":471,"PHASE1":473,"PHASE2":475,"PHASE3":477,"PHASE4":479,"NA":492},{"trials":472,"activeCount":100},[],{"trials":474,"activeCount":100},[],{"trials":476,"activeCount":100},[],{"trials":478,"activeCount":100},[],{"trials":480,"activeCount":100},[481],{"nctId":482,"briefTitle":483,"status":124,"phases":484,"primaryCompletion":485,"completion":486,"start":487,"enrollment":488,"conditions":489,"interventions":490},"NCT03886896","Intravenous Lidocaine in Children Undergoing Laparoscopic Appendectomy",[91],"2020-01-15","2020-01-17","2019-03-22",74,[118,182,183],[491],"Lidocaine",{"trials":493,"activeCount":134,"soonestReadout":64},[494],{"nctId":62,"briefTitle":63,"status":394,"phases":495,"primaryCompletion":64,"completion":496,"start":497,"enrollment":498,"conditions":499,"interventions":501},[92],"2027-05-30","2025-06-01",94,[500],"Postoperative Pain After Laparoscopic Liver Resection",[65],{"intervention":50,"totalTrials":134,"cells":503},{"EARLY_PHASE1":504,"PHASE1":506,"PHASE2":508,"PHASE3":510,"PHASE4":512,"NA":514},{"trials":505,"activeCount":100},[],{"trials":507,"activeCount":100},[],{"trials":509,"activeCount":100},[],{"trials":511,"activeCount":100},[],{"trials":513,"activeCount":100},[],{"trials":515,"activeCount":134,"soonestReadout":49},[516],{"nctId":47,"briefTitle":48,"status":110,"phases":517,"primaryCompletion":49,"completion":518,"start":519,"enrollment":520,"conditions":521,"interventions":522},[92],"2027-04-21","2024-03-28",39,[18],[50],{"intervention":70,"totalTrials":134,"cells":524},{"EARLY_PHASE1":525,"PHASE1":527,"PHASE2":529,"PHASE3":531,"PHASE4":533,"NA":535},{"trials":526,"activeCount":100},[],{"trials":528,"activeCount":100},[],{"trials":530,"activeCount":100},[],{"trials":532,"activeCount":100},[],{"trials":534,"activeCount":100},[],{"trials":536,"activeCount":134,"soonestReadout":69},[537],{"nctId":67,"briefTitle":68,"status":394,"phases":538,"primaryCompletion":69,"completion":539,"start":540,"enrollment":541,"conditions":542,"interventions":548},[92],"2027-04-30","2025-10",424,[543,544,545,546,70,547],"Clostridioides Difficile Infection","Clostridioides Difficile Infection Recurrence","Fecal Microbiota Transplantation (FMT)","Comparative Effectiveness of CDI Treatments","Vancomycin",[70,549],"Vancomycin (VAN) treatment",{"intervention":549,"totalTrials":134,"cells":551},{"EARLY_PHASE1":552,"PHASE1":554,"PHASE2":556,"PHASE3":558,"PHASE4":560,"NA":562},{"trials":553,"activeCount":100},[],{"trials":555,"activeCount":100},[],{"trials":557,"activeCount":100},[],{"trials":559,"activeCount":100},[],{"trials":561,"activeCount":100},[],{"trials":563,"activeCount":134,"soonestReadout":69},[564],{"nctId":67,"briefTitle":68,"status":394,"phases":565,"primaryCompletion":69,"completion":539,"start":540,"enrollment":541,"conditions":566,"interventions":567},[92],[543,544,545,546,70,547],[70,549],{"intervention":569,"totalTrials":134,"cells":570},"Non-selective beta-blockers",{"EARLY_PHASE1":571,"PHASE1":573,"PHASE2":575,"PHASE3":577,"PHASE4":579,"NA":581},{"trials":572,"activeCount":100},[],{"trials":574,"activeCount":100},[],{"trials":576,"activeCount":100},[],{"trials":578,"activeCount":100},[],{"trials":580,"activeCount":100},[],{"trials":582,"activeCount":134,"soonestReadout":587},[583],{"nctId":584,"briefTitle":585,"status":110,"phases":586,"primaryCompletion":587,"completion":588,"start":589,"enrollment":590,"conditions":591,"interventions":593},"NCT07111221","Portal Inflow Modulation Prior to Liver Transplantation in Patients With Increased Risk of Intraoperative Blood Loss",[92],"2029-10","2029-12","2025-06-24",104,[30,592],"Clinically Significant Portal Hypertension",[569],{"intervention":595,"totalTrials":28,"cells":596},"Insulin aspart",{"EARLY_PHASE1":597,"PHASE1":599,"PHASE2":601,"PHASE3":603,"PHASE4":605,"NA":667},{"trials":598,"activeCount":100},[],{"trials":600,"activeCount":100},[],{"trials":602,"activeCount":100},[],{"trials":604,"activeCount":100},[],{"trials":606,"activeCount":100},[607,620,631,645,655],{"nctId":608,"briefTitle":609,"status":124,"phases":610,"primaryCompletion":611,"completion":611,"start":612,"enrollment":613,"conditions":614,"interventions":616},"NCT02276859","Normal Versus Dual Wave Insulin Bolus for High-protein Food",[91],"2015-09","2014-10",70,[615],"Type 1 Diabetes",[617,618,619],"insulin aspart","insulin lispro","insulin glulisine",{"nctId":621,"briefTitle":622,"status":124,"phases":623,"primaryCompletion":624,"completion":624,"start":625,"enrollment":626,"conditions":627,"interventions":629},"NCT01678235","Insulin Glulisine and Aspart in Postprandial Glycemic Control After High-GI Meal in Children With Type 1 Diabetes Mellitus",[91],"2012-09","2011-09",64,[628],"Type 1 Diabetes Mellitus",[630,595],"Insulin glulisine",{"nctId":632,"briefTitle":633,"status":124,"phases":634,"primaryCompletion":635,"completion":636,"start":637,"enrollment":638,"conditions":639,"interventions":641},"NCT04124302","The Impact of Two Different Insulin Dose Calculation on Postprandial Glycemia After Mixed Meal.",[91],"2024-03-27","2024-12-31","2019-10-01",76,[640],"Diabetes Mellitus, Type 1",[642,643,644],"Insulin Glulisine","Insulin Aspart","Insulin Lispro",{"nctId":646,"briefTitle":647,"status":124,"phases":648,"primaryCompletion":649,"completion":650,"start":651,"enrollment":652,"conditions":653,"interventions":654},"NCT04019821","Super-Bolus: Effects on Postprandial Glycemia After High Glycemic Index Meal",[91],"2023-01-01","2023-04-01","2020-01-01",72,[640],[642,643,644],{"nctId":656,"briefTitle":657,"status":658,"phases":659,"primaryCompletion":660,"completion":661,"start":662,"enrollment":613,"conditions":663,"interventions":665},"NCT02685449","Insulin Requirement for Pure-protein Meal in Children With Type 1 Diabetes on Insulin Pumps.","UNKNOWN",[91],"2018-02","2018-08","2016-02",[664],"Diabetes type1",[630,595,666],"Insulin lispro",{"trials":668,"activeCount":100},[],{"intervention":630,"totalTrials":28,"cells":670},{"EARLY_PHASE1":671,"PHASE1":673,"PHASE2":675,"PHASE3":677,"PHASE4":679,"NA":701},{"trials":672,"activeCount":100},[],{"trials":674,"activeCount":100},[],{"trials":676,"activeCount":100},[],{"trials":678,"activeCount":100},[],{"trials":680,"activeCount":100},[681,685,689,693,697],{"nctId":608,"briefTitle":609,"status":124,"phases":682,"primaryCompletion":611,"completion":611,"start":612,"enrollment":613,"conditions":683,"interventions":684},[91],[615],[617,618,619],{"nctId":621,"briefTitle":622,"status":124,"phases":686,"primaryCompletion":624,"completion":624,"start":625,"enrollment":626,"conditions":687,"interventions":688},[91],[628],[630,595],{"nctId":632,"briefTitle":633,"status":124,"phases":690,"primaryCompletion":635,"completion":636,"start":637,"enrollment":638,"conditions":691,"interventions":692},[91],[640],[642,643,644],{"nctId":646,"briefTitle":647,"status":124,"phases":694,"primaryCompletion":649,"completion":650,"start":651,"enrollment":652,"conditions":695,"interventions":696},[91],[640],[642,643,644],{"nctId":656,"briefTitle":657,"status":658,"phases":698,"primaryCompletion":660,"completion":661,"start":662,"enrollment":613,"conditions":699,"interventions":700},[91],[664],[630,595,666],{"trials":702,"activeCount":100},[],{"intervention":644,"totalTrials":704,"cells":705},4,{"EARLY_PHASE1":706,"PHASE1":708,"PHASE2":710,"PHASE3":712,"PHASE4":714,"NA":732},{"trials":707,"activeCount":100},[],{"trials":709,"activeCount":100},[],{"trials":711,"activeCount":100},[],{"trials":713,"activeCount":100},[],{"trials":715,"activeCount":100},[716,720,724,728],{"nctId":608,"briefTitle":609,"status":124,"phases":717,"primaryCompletion":611,"completion":611,"start":612,"enrollment":613,"conditions":718,"interventions":719},[91],[615],[617,618,619],{"nctId":632,"briefTitle":633,"status":124,"phases":721,"primaryCompletion":635,"completion":636,"start":637,"enrollment":638,"conditions":722,"interventions":723},[91],[640],[642,643,644],{"nctId":646,"briefTitle":647,"status":124,"phases":725,"primaryCompletion":649,"completion":650,"start":651,"enrollment":652,"conditions":726,"interventions":727},[91],[640],[642,643,644],{"nctId":656,"briefTitle":657,"status":658,"phases":729,"primaryCompletion":660,"completion":661,"start":662,"enrollment":613,"conditions":730,"interventions":731},[91],[664],[630,595,666],{"trials":733,"activeCount":100},[],{"intervention":735,"totalTrials":96,"cells":736},"Polyethylene glycol 4000",{"EARLY_PHASE1":737,"PHASE1":739,"PHASE2":741,"PHASE3":743,"PHASE4":757,"NA":769},{"trials":738,"activeCount":100},[],{"trials":740,"activeCount":100},[],{"trials":742,"activeCount":100},[],{"trials":744,"activeCount":100},[745],{"nctId":746,"briefTitle":747,"status":658,"phases":748,"primaryCompletion":749,"completion":750,"start":751,"enrollment":752,"conditions":753,"interventions":755},"NCT03639142","Dried Plums (Prunes) vs. Polyethylene Glycol 4000 for Treatment of Functional Constipation in Children",[90],"2020-09-01","2020-11-01","2018-09-01",110,[754],"Functional Constipation",[756],"Polyethylene Glycol 4000",{"trials":758,"activeCount":100},[759],{"nctId":760,"briefTitle":761,"status":124,"phases":762,"primaryCompletion":763,"completion":764,"start":765,"enrollment":180,"conditions":766,"interventions":768},"NCT01875744","Polyethylene Glycol for Childhood Constipation",[91],"2013-11","2013-11-30","2013-06",[767],"Constipation",[735],{"trials":770,"activeCount":100},[],{"intervention":772,"totalTrials":134,"cells":773},"Bupivacaine-fentanyl",{"EARLY_PHASE1":774,"PHASE1":776,"PHASE2":778,"PHASE3":780,"PHASE4":782,"NA":798},{"trials":775,"activeCount":100},[],{"trials":777,"activeCount":100},[],{"trials":779,"activeCount":100},[],{"trials":781,"activeCount":100},[],{"trials":783,"activeCount":100},[784],{"nctId":785,"briefTitle":786,"status":124,"phases":787,"primaryCompletion":788,"completion":789,"start":790,"enrollment":791,"conditions":792,"interventions":797},"NCT02988219","Cardiac Arrhythmias in Patients Undergoing Kidney Cancer Surgery Depending on the Anaesthesia Method",[91],"2014-12","2016-12","2010-06",50,[793,794,795,796],"Arrhythmia, Cardiac","Kidney Cancer","Surgery","Anesthesia, Local",[772],{"trials":799,"activeCount":100},[],{"intervention":801,"totalTrials":134,"cells":802},"Tramadol Hydrochloride",{"EARLY_PHASE1":803,"PHASE1":805,"PHASE2":807,"PHASE3":809,"PHASE4":811,"NA":823},{"trials":804,"activeCount":100},[],{"trials":806,"activeCount":100},[],{"trials":808,"activeCount":100},[],{"trials":810,"activeCount":100},[],{"trials":812,"activeCount":100},[813],{"nctId":814,"briefTitle":815,"status":124,"phases":816,"primaryCompletion":817,"completion":818,"start":819,"enrollment":439,"conditions":820,"interventions":822},"NCT03477851","Tramadol Simultaneously With Sciatic Nerve Block for Calcaneus Fracture Osteosynthesis",[91],"2020-06-30","2020-12-30","2017-06-15",[821,155],"Foot Fracture",[801],{"trials":824,"activeCount":100},[],{"intervention":826,"totalTrials":134,"cells":827},"Ticagrelor",{"EARLY_PHASE1":828,"PHASE1":830,"PHASE2":832,"PHASE3":834,"PHASE4":836,"NA":850},{"trials":829,"activeCount":100},[],{"trials":831,"activeCount":100},[],{"trials":833,"activeCount":100},[],{"trials":835,"activeCount":100},[],{"trials":837,"activeCount":100},[838],{"nctId":839,"briefTitle":840,"status":124,"phases":841,"primaryCompletion":842,"completion":843,"start":844,"enrollment":845,"conditions":846,"interventions":848},"NCT02931045","Antiplatelet Therapy Effect on Extracellular Vesicles in Acute Myocardial Infarction",[91],"2018-12-30","2019-12-30","2017-12-30",60,[847],"Myocardial Infarction",[826,849],"Clopidogrel",{"trials":851,"activeCount":100},[],{"intervention":849,"totalTrials":134,"cells":853},{"EARLY_PHASE1":854,"PHASE1":856,"PHASE2":858,"PHASE3":860,"PHASE4":862,"NA":868},{"trials":855,"activeCount":100},[],{"trials":857,"activeCount":100},[],{"trials":859,"activeCount":100},[],{"trials":861,"activeCount":100},[],{"trials":863,"activeCount":100},[864],{"nctId":839,"briefTitle":840,"status":124,"phases":865,"primaryCompletion":842,"completion":843,"start":844,"enrollment":845,"conditions":866,"interventions":867},[91],[847],[826,849],{"trials":869,"activeCount":100},[],{"intervention":871,"totalTrials":134,"cells":872},"Insulin faster aspart",{"EARLY_PHASE1":873,"PHASE1":875,"PHASE2":877,"PHASE3":879,"PHASE4":881,"NA":893},{"trials":874,"activeCount":100},[],{"trials":876,"activeCount":100},[],{"trials":878,"activeCount":100},[],{"trials":880,"activeCount":100},[],{"trials":882,"activeCount":100},[883],{"nctId":884,"briefTitle":885,"status":658,"phases":886,"primaryCompletion":887,"completion":888,"start":889,"enrollment":890,"conditions":891,"interventions":892},"NCT04772729","Does the Use of Fiasp vs. Asp Lead to the Prolonged TIR in Children With Type 1 Diabetes?",[91],"2023-03-01","2024-03-01","2021-03-01",77,[664,640],[871],{"trials":894,"activeCount":100},[],{"intervention":896,"totalTrials":134,"cells":897},"Vitamin D3",{"EARLY_PHASE1":898,"PHASE1":900,"PHASE2":902,"PHASE3":904,"PHASE4":906,"NA":916},{"trials":899,"activeCount":100},[],{"trials":901,"activeCount":100},[],{"trials":903,"activeCount":100},[],{"trials":905,"activeCount":100},[],{"trials":907,"activeCount":100},[908],{"nctId":909,"briefTitle":910,"status":124,"phases":911,"primaryCompletion":763,"completion":763,"start":912,"enrollment":845,"conditions":913,"interventions":915},"NCT01277913","The Effect of Supplementation With Two Different Doses of Vitamin D on Bone Mineral Density, Vitamin D Levels and Hand Grip Strength in Children With Diabetes Mellitus Type 1",[91],"2011-01",[914],"Diabetes Mellitus Type 1",[896,896],{"trials":917,"activeCount":100},[],{"intervention":919,"totalTrials":134,"cells":920},"Vaxigrip",{"EARLY_PHASE1":921,"PHASE1":923,"PHASE2":925,"PHASE3":927,"PHASE4":929,"NA":947},{"trials":922,"activeCount":100},[],{"trials":924,"activeCount":100},[],{"trials":926,"activeCount":100},[],{"trials":928,"activeCount":100},[],{"trials":930,"activeCount":100},[931],{"nctId":932,"briefTitle":933,"status":658,"phases":934,"primaryCompletion":935,"completion":936,"start":937,"enrollment":938,"conditions":939,"interventions":946},"NCT06286488","Effectiveness and Tolerability of Influenza Vaccine in Patients at Risk for Severe and Complicated Influenza",[91],"2023-08-23","2026-05-01","2020-09-15",1500,[940,21,941,942,943,944,945],"Influenza","Pregnancy; Infection","Elderly Infection","Vaccine Reaction","Vaccine Adverse Reaction","Tolerance",[919],{"trials":948,"activeCount":100},[],{"intervention":950,"totalTrials":134,"cells":951},"lidocaine 2%",{"EARLY_PHASE1":952,"PHASE1":954,"PHASE2":956,"PHASE3":958,"PHASE4":960,"NA":973},{"trials":953,"activeCount":100},[],{"trials":955,"activeCount":100},[],{"trials":957,"activeCount":100},[],{"trials":959,"activeCount":100},[],{"trials":961,"activeCount":100},[962],{"nctId":963,"briefTitle":964,"status":658,"phases":965,"primaryCompletion":966,"completion":966,"start":662,"enrollment":227,"conditions":967,"interventions":971},"NCT02696733","Ultrasound-Guided ONB for Transurethral Procedures - Interadductor Approach",[91],"2017-12",[968,969,970],"Urinary Bladder Neoplasms","Transurethral Resection","Nerve Block",[950,972],"0.9% Natrium Chloratum with a 2nd generation cephalosporin",{"trials":974,"activeCount":100},[],{"intervention":972,"totalTrials":134,"cells":976},{"EARLY_PHASE1":977,"PHASE1":979,"PHASE2":981,"PHASE3":983,"PHASE4":985,"NA":991},{"trials":978,"activeCount":100},[],{"trials":980,"activeCount":100},[],{"trials":982,"activeCount":100},[],{"trials":984,"activeCount":100},[],{"trials":986,"activeCount":100},[987],{"nctId":963,"briefTitle":964,"status":658,"phases":988,"primaryCompletion":966,"completion":966,"start":662,"enrollment":227,"conditions":989,"interventions":990},[91],[968,969,970],[950,972],{"trials":992,"activeCount":100},[],{"intervention":994,"totalTrials":134,"cells":995},"every week IVMP therapy",{"EARLY_PHASE1":996,"PHASE1":998,"PHASE2":1000,"PHASE3":1002,"PHASE4":1004,"NA":1030},{"trials":997,"activeCount":100},[],{"trials":999,"activeCount":100},[],{"trials":1001,"activeCount":100},[],{"trials":1003,"activeCount":100},[],{"trials":1005,"activeCount":100},[1006],{"nctId":1007,"briefTitle":1008,"status":124,"phases":1009,"primaryCompletion":1010,"completion":1010,"start":1011,"enrollment":1012,"conditions":1013,"interventions":1028},"NCT03667157","Liver Function After Intravenous Methylprednisolone Administration",[91],"2016-10-30","2012-01-01",68,[1014,1015,1016,1017,1018,1019,1020,1021,1022,1023,1024,1025,1026,1027],"Graves Disease","Graves Ophthalmopathy","Liver Diseases","Liver Failure","Liver Injury","Liver Dysfunction","Liver Insufficiency","Acute Liver Failure","Acute Liver Injury","Acute Liver Injury, Drug Induced","Methylprednisolone Adverse Reaction","Glucocorticoids Toxicity","Dysthyroid Orbitopathy","Dysthyroid Ophthalmopathy",[994,1029],"very high doses IVMP therapy",{"trials":1031,"activeCount":100},[],{"intervention":1029,"totalTrials":134,"cells":1033},{"EARLY_PHASE1":1034,"PHASE1":1036,"PHASE2":1038,"PHASE3":1040,"PHASE4":1042,"NA":1048},{"trials":1035,"activeCount":100},[],{"trials":1037,"activeCount":100},[],{"trials":1039,"activeCount":100},[],{"trials":1041,"activeCount":100},[],{"trials":1043,"activeCount":100},[1044],{"nctId":1007,"briefTitle":1008,"status":124,"phases":1045,"primaryCompletion":1010,"completion":1010,"start":1011,"enrollment":1012,"conditions":1046,"interventions":1047},[91],[1014,1015,1016,1017,1018,1019,1020,1021,1022,1023,1024,1025,1026,1027],[994,1029],{"trials":1049,"activeCount":100},[],{"intervention":1051,"totalTrials":134,"cells":1052},"Dexmedetomidine Hydrochloride [Dexdor]",{"EARLY_PHASE1":1053,"PHASE1":1055,"PHASE2":1057,"PHASE3":1059,"PHASE4":1061,"NA":1080},{"trials":1054,"activeCount":100},[],{"trials":1056,"activeCount":100},[],{"trials":1058,"activeCount":100},[],{"trials":1060,"activeCount":100},[],{"trials":1062,"activeCount":100},[1063],{"nctId":1064,"briefTitle":1065,"status":124,"phases":1066,"primaryCompletion":1067,"completion":1068,"start":1069,"enrollment":1070,"conditions":1071,"interventions":1074},"NCT04260659","Opioid Free vs Opioid Based Anesthesia for Laparoscopic Sleeve Gastrectomy",[91],"2022-10-06","2023-02-22","2020-02-04",59,[21,182,1072,1073,184],"Postoperative Nausea","Postoperative Vomiting",[1051,1075,1076,1077,1078,1079],"Remifentanil [Ultiva]","Ketamine [Ketalar]","Lidocaine [Xylocaine 2%]","Magnesium Sulphate [Inj. Magnesii Sulfurici Polpharma]","Fentanyl [Fentanyl WZF]",{"trials":1081,"activeCount":100},[],{"intervention":1075,"totalTrials":134,"cells":1083},{"EARLY_PHASE1":1084,"PHASE1":1086,"PHASE2":1088,"PHASE3":1090,"PHASE4":1092,"NA":1098},{"trials":1085,"activeCount":100},[],{"trials":1087,"activeCount":100},[],{"trials":1089,"activeCount":100},[],{"trials":1091,"activeCount":100},[],{"trials":1093,"activeCount":100},[1094],{"nctId":1064,"briefTitle":1065,"status":124,"phases":1095,"primaryCompletion":1067,"completion":1068,"start":1069,"enrollment":1070,"conditions":1096,"interventions":1097},[91],[21,182,1072,1073,184],[1051,1075,1076,1077,1078,1079],{"trials":1099,"activeCount":100},[],{"intervention":1076,"totalTrials":134,"cells":1101},{"EARLY_PHASE1":1102,"PHASE1":1104,"PHASE2":1106,"PHASE3":1108,"PHASE4":1110,"NA":1116},{"trials":1103,"activeCount":100},[],{"trials":1105,"activeCount":100},[],{"trials":1107,"activeCount":100},[],{"trials":1109,"activeCount":100},[],{"trials":1111,"activeCount":100},[1112],{"nctId":1064,"briefTitle":1065,"status":124,"phases":1113,"primaryCompletion":1067,"completion":1068,"start":1069,"enrollment":1070,"conditions":1114,"interventions":1115},[91],[21,182,1072,1073,184],[1051,1075,1076,1077,1078,1079],{"trials":1117,"activeCount":100},[],{"intervention":1077,"totalTrials":134,"cells":1119},{"EARLY_PHASE1":1120,"PHASE1":1122,"PHASE2":1124,"PHASE3":1126,"PHASE4":1128,"NA":1134},{"trials":1121,"activeCount":100},[],{"trials":1123,"activeCount":100},[],{"trials":1125,"activeCount":100},[],{"trials":1127,"activeCount":100},[],{"trials":1129,"activeCount":100},[1130],{"nctId":1064,"briefTitle":1065,"status":124,"phases":1131,"primaryCompletion":1067,"completion":1068,"start":1069,"enrollment":1070,"conditions":1132,"interventions":1133},[91],[21,182,1072,1073,184],[1051,1075,1076,1077,1078,1079],{"trials":1135,"activeCount":100},[],{"intervention":1078,"totalTrials":134,"cells":1137},{"EARLY_PHASE1":1138,"PHASE1":1140,"PHASE2":1142,"PHASE3":1144,"PHASE4":1146,"NA":1152},{"trials":1139,"activeCount":100},[],{"trials":1141,"activeCount":100},[],{"trials":1143,"activeCount":100},[],{"trials":1145,"activeCount":100},[],{"trials":1147,"activeCount":100},[1148],{"nctId":1064,"briefTitle":1065,"status":124,"phases":1149,"primaryCompletion":1067,"completion":1068,"start":1069,"enrollment":1070,"conditions":1150,"interventions":1151},[91],[21,182,1072,1073,184],[1051,1075,1076,1077,1078,1079],{"trials":1153,"activeCount":100},[],{"intervention":1079,"totalTrials":134,"cells":1155},{"EARLY_PHASE1":1156,"PHASE1":1158,"PHASE2":1160,"PHASE3":1162,"PHASE4":1164,"NA":1170},{"trials":1157,"activeCount":100},[],{"trials":1159,"activeCount":100},[],{"trials":1161,"activeCount":100},[],{"trials":1163,"activeCount":100},[],{"trials":1165,"activeCount":100},[1166],{"nctId":1064,"briefTitle":1065,"status":124,"phases":1167,"primaryCompletion":1067,"completion":1068,"start":1069,"enrollment":1070,"conditions":1168,"interventions":1169},[91],[21,182,1072,1073,184],[1051,1075,1076,1077,1078,1079],{"trials":1171,"activeCount":100},[],{"intervention":1173,"totalTrials":134,"cells":1174},"Midazolam Oral",{"EARLY_PHASE1":1175,"PHASE1":1177,"PHASE2":1179,"PHASE3":1181,"PHASE4":1183,"NA":1195},{"trials":1176,"activeCount":100},[],{"trials":1178,"activeCount":100},[],{"trials":1180,"activeCount":100},[],{"trials":1182,"activeCount":100},[],{"trials":1184,"activeCount":100},[1185],{"nctId":1186,"briefTitle":1187,"status":124,"phases":1188,"primaryCompletion":1189,"completion":1189,"start":1190,"enrollment":439,"conditions":1191,"interventions":1194},"NCT03474939","The Effect of Midazolam Premedication on Copeptine Concentration in Blood",[91],"2019-03-01","2017-04-03",[1192,1193],"Preanesthetic Medication","Copeptin",[1173],{"trials":1196,"activeCount":100},[],{"intervention":1198,"totalTrials":134,"cells":1199},"Glucomannan",{"EARLY_PHASE1":1200,"PHASE1":1202,"PHASE2":1204,"PHASE3":1206,"PHASE4":1208,"NA":1220},{"trials":1201,"activeCount":100},[],{"trials":1203,"activeCount":100},[],{"trials":1205,"activeCount":100},[],{"trials":1207,"activeCount":100},[],{"trials":1209,"activeCount":100},[1210],{"nctId":1211,"briefTitle":1212,"status":124,"phases":1213,"primaryCompletion":1214,"completion":1214,"start":1215,"enrollment":1216,"conditions":1217,"interventions":1219},"NCT01495806","Glucomannan for the Treatment of Abdominal Pain-related Functional Gastrointestinal Disorders in Childhood",[91],"2012-01","2010-01",89,[1218],"Functional Gastrointestinal Disorders",[1198],{"trials":1221,"activeCount":100},[],{"intervention":1223,"totalTrials":134,"cells":1224},"polyethylene glycol +Bisacodyl",{"EARLY_PHASE1":1225,"PHASE1":1227,"PHASE2":1229,"PHASE3":1231,"PHASE4":1233,"NA":1246},{"trials":1226,"activeCount":100},[],{"trials":1228,"activeCount":100},[],{"trials":1230,"activeCount":100},[],{"trials":1232,"activeCount":100},[],{"trials":1234,"activeCount":100},[1235],{"nctId":1236,"briefTitle":1237,"status":124,"phases":1238,"primaryCompletion":1239,"completion":1239,"start":1240,"enrollment":12,"conditions":1241,"interventions":1243},"NCT01531140","PEG Versus PEG+Bisacodyl Versus Sennosides for Colon Cleansing Before Colonoscopy",[91],"2011-11","2010-11",[1242],"Colonoscopy Preparation",[1223,1244,1245],"Polyethylene glycol","Sennosides",{"trials":1247,"activeCount":100},[],{"intervention":1244,"totalTrials":134,"cells":1249},{"EARLY_PHASE1":1250,"PHASE1":1252,"PHASE2":1254,"PHASE3":1256,"PHASE4":1258,"NA":1264},{"trials":1251,"activeCount":100},[],{"trials":1253,"activeCount":100},[],{"trials":1255,"activeCount":100},[],{"trials":1257,"activeCount":100},[],{"trials":1259,"activeCount":100},[1260],{"nctId":1236,"briefTitle":1237,"status":124,"phases":1261,"primaryCompletion":1239,"completion":1239,"start":1240,"enrollment":12,"conditions":1262,"interventions":1263},[91],[1242],[1223,1244,1245],{"trials":1265,"activeCount":100},[],{"intervention":1245,"totalTrials":134,"cells":1267},{"EARLY_PHASE1":1268,"PHASE1":1270,"PHASE2":1272,"PHASE3":1274,"PHASE4":1276,"NA":1282},{"trials":1269,"activeCount":100},[],{"trials":1271,"activeCount":100},[],{"trials":1273,"activeCount":100},[],{"trials":1275,"activeCount":100},[],{"trials":1277,"activeCount":100},[1278],{"nctId":1236,"briefTitle":1237,"status":124,"phases":1279,"primaryCompletion":1239,"completion":1239,"start":1240,"enrollment":12,"conditions":1280,"interventions":1281},[91],[1242],[1223,1244,1245],{"trials":1283,"activeCount":100},[],{"intervention":1285,"totalTrials":134,"cells":1286},"Protamine sulfate",{"EARLY_PHASE1":1287,"PHASE1":1289,"PHASE2":1291,"PHASE3":1293,"PHASE4":1295,"NA":1307},{"trials":1288,"activeCount":100},[],{"trials":1290,"activeCount":100},[],{"trials":1292,"activeCount":100},[],{"trials":1294,"activeCount":100},[],{"trials":1296,"activeCount":100},[1297],{"nctId":1298,"briefTitle":1299,"status":124,"phases":1300,"primaryCompletion":1301,"completion":1302,"start":789,"enrollment":227,"conditions":1303,"interventions":1305},"NCT02974660","Protamine Sulfate During Transcatheter Aortic Valve Implantation",[91],"2020-07","2020-09",[1304],"Aortic Valve Stenosis",[1285,1306],"0.9% NaCl",{"trials":1308,"activeCount":100},[],{"intervention":1306,"totalTrials":134,"cells":1310},{"EARLY_PHASE1":1311,"PHASE1":1313,"PHASE2":1315,"PHASE3":1317,"PHASE4":1319,"NA":1325},{"trials":1312,"activeCount":100},[],{"trials":1314,"activeCount":100},[],{"trials":1316,"activeCount":100},[],{"trials":1318,"activeCount":100},[],{"trials":1320,"activeCount":100},[1321],{"nctId":1298,"briefTitle":1299,"status":124,"phases":1322,"primaryCompletion":1301,"completion":1302,"start":789,"enrollment":227,"conditions":1323,"interventions":1324},[91],[1304],[1285,1306],{"trials":1326,"activeCount":100},[],{"intervention":1328,"totalTrials":134,"cells":1329},"TachoSil",{"EARLY_PHASE1":1330,"PHASE1":1332,"PHASE2":1334,"PHASE3":1336,"PHASE4":1338,"NA":1351},{"trials":1331,"activeCount":100},[],{"trials":1333,"activeCount":100},[],{"trials":1335,"activeCount":100},[],{"trials":1337,"activeCount":100},[],{"trials":1339,"activeCount":100},[1340],{"nctId":1341,"briefTitle":1342,"status":658,"phases":1343,"primaryCompletion":1344,"completion":1345,"start":1346,"enrollment":1347,"conditions":1348,"interventions":1350},"NCT06124209","Use of Fibrin Sealant Patch for Vein Anastomosis During Deceased Donor Liver Transplantation- Randomized Clinical Trial",[91],"2025-12-01","2026-03-01","2023-11-04",170,[1349],"Liver Transplant; Complications",[1328],{"trials":1352,"activeCount":100},[],{"intervention":1354,"totalTrials":134,"cells":1355},"Iron",{"EARLY_PHASE1":1356,"PHASE1":1358,"PHASE2":1360,"PHASE3":1362,"PHASE4":1364,"NA":1376},{"trials":1357,"activeCount":100},[],{"trials":1359,"activeCount":100},[],{"trials":1361,"activeCount":100},[],{"trials":1363,"activeCount":100},[],{"trials":1365,"activeCount":100},[1366],{"nctId":1367,"briefTitle":1368,"status":658,"phases":1369,"primaryCompletion":1370,"completion":1371,"start":611,"enrollment":1372,"conditions":1373,"interventions":1375},"NCT02242188","Supplementing Iron and Development in Breastfed Infants (SIDBI Study)",[91],"2019-01","2019-06",220,[1374],"Iron Deficiency",[1354],{"trials":1377,"activeCount":100},[],{"intervention":1379,"totalTrials":134,"cells":1380},"Furosemide",{"EARLY_PHASE1":1381,"PHASE1":1383,"PHASE2":1385,"PHASE3":1387,"PHASE4":1389,"NA":1400},{"trials":1382,"activeCount":100},[],{"trials":1384,"activeCount":100},[],{"trials":1386,"activeCount":100},[],{"trials":1388,"activeCount":100},[],{"trials":1390,"activeCount":100},[1391],{"nctId":1392,"briefTitle":1393,"status":658,"phases":1394,"primaryCompletion":966,"completion":1395,"start":1396,"enrollment":227,"conditions":1397,"interventions":1398},"NCT01942109","The Impact of TORasemide oN hemodynAmic and Neurohormonal Stress, and carDiac remOdeling in Heart Failure",[91],"2018-12","2013-09",[15],[1379,1399],"Torasemide",{"trials":1401,"activeCount":100},[],{"intervention":1399,"totalTrials":134,"cells":1403},{"EARLY_PHASE1":1404,"PHASE1":1406,"PHASE2":1408,"PHASE3":1410,"PHASE4":1412,"NA":1418},{"trials":1405,"activeCount":100},[],{"trials":1407,"activeCount":100},[],{"trials":1409,"activeCount":100},[],{"trials":1411,"activeCount":100},[],{"trials":1413,"activeCount":100},[1414],{"nctId":1392,"briefTitle":1393,"status":658,"phases":1415,"primaryCompletion":966,"completion":1395,"start":1396,"enrollment":227,"conditions":1416,"interventions":1417},[91],[15],[1379,1399],{"trials":1419,"activeCount":100},[],{"intervention":1421,"totalTrials":134,"cells":1422},"Bupivacaine",{"EARLY_PHASE1":1423,"PHASE1":1425,"PHASE2":1427,"PHASE3":1429,"PHASE4":1431,"NA":1442},{"trials":1424,"activeCount":100},[],{"trials":1426,"activeCount":100},[],{"trials":1428,"activeCount":100},[],{"trials":1430,"activeCount":100},[],{"trials":1432,"activeCount":100},[1433],{"nctId":1434,"briefTitle":1435,"status":124,"phases":1436,"primaryCompletion":1437,"completion":1438,"start":1439,"enrollment":590,"conditions":1440,"interventions":1441},"NCT02783586","TAPB vs QLBII for Kidney Transplantation Procedure",[91],"2017-05-29","2017-05-30","2016-04-08",[182],[1421],{"trials":1443,"activeCount":100},[],{"intervention":1445,"totalTrials":134,"cells":1446},"Lactobacillus rhamnosus GG and Bifidobacterium lactis BB12",{"EARLY_PHASE1":1447,"PHASE1":1449,"PHASE2":1451,"PHASE3":1453,"PHASE4":1455,"NA":1465},{"trials":1448,"activeCount":100},[],{"trials":1450,"activeCount":100},[],{"trials":1452,"activeCount":100},[],{"trials":1454,"activeCount":100},[],{"trials":1456,"activeCount":100},[1457],{"nctId":1458,"briefTitle":1459,"status":658,"phases":1460,"primaryCompletion":1395,"completion":1395,"start":1461,"enrollment":1462,"conditions":1463,"interventions":1464},"NCT03032354","Probiotics in Newly Recognized Type 1 Diabetes",[91],"2017-07-15",96,[640],[1445],{"trials":1466,"activeCount":100},[],{"intervention":1468,"totalTrials":134,"cells":1469},"Ivabradine",{"EARLY_PHASE1":1470,"PHASE1":1472,"PHASE2":1474,"PHASE3":1476,"PHASE4":1478,"NA":1489},{"trials":1471,"activeCount":100},[],{"trials":1473,"activeCount":100},[],{"trials":1475,"activeCount":100},[],{"trials":1477,"activeCount":100},[],{"trials":1479,"activeCount":100},[1480],{"nctId":1481,"briefTitle":1482,"status":658,"phases":1483,"primaryCompletion":1484,"completion":1485,"start":1486,"enrollment":845,"conditions":1487,"interventions":1488},"NCT02166060","Ivabradine in Patients With an Unsatisfactory Percentage of Cardiac Resynchronization Therapy",[91],"2016-08","2016-10","2014-08",[15],[1468],{"trials":1490,"activeCount":100},[],{"intervention":1492,"totalTrials":134,"cells":1493},"Lactobacillus reuteri DSM 17938",{"EARLY_PHASE1":1494,"PHASE1":1496,"PHASE2":1498,"PHASE3":1500,"PHASE4":1502,"NA":1513},{"trials":1495,"activeCount":100},[],{"trials":1497,"activeCount":100},[],{"trials":1499,"activeCount":100},[],{"trials":1501,"activeCount":100},[],{"trials":1503,"activeCount":100},[1504],{"nctId":1505,"briefTitle":1506,"status":124,"phases":1507,"primaryCompletion":1508,"completion":1508,"start":789,"enrollment":1509,"conditions":1510,"interventions":1512},"NCT02871908","Lactobacillus Reuteri DSM 17938 in the Prevention of Antibiotic-associated Diarrhea in Children: Protocol of a Randomized Controlled Trial",[91],"2018-03",250,[34,1511],"Antibiotic Associated Diarrhea",[1492],{"trials":1514,"activeCount":100},[],{"intervention":1516,"totalTrials":134,"cells":1517},"Sufentanil",{"EARLY_PHASE1":1518,"PHASE1":1520,"PHASE2":1522,"PHASE3":1524,"PHASE4":1526,"NA":1541},{"trials":1519,"activeCount":100},[],{"trials":1521,"activeCount":100},[],{"trials":1523,"activeCount":100},[],{"trials":1525,"activeCount":100},[],{"trials":1527,"activeCount":100},[1528],{"nctId":1529,"briefTitle":1530,"status":658,"phases":1531,"primaryCompletion":1532,"completion":1532,"start":1533,"enrollment":1534,"conditions":1535,"interventions":1539},"NCT03344042","Effect of Epidural Opioid Administered in the First A Period on the Progress of Labour",[91],"2018-12-20","2017-12-01",300,[1536,1537,1538],"Anesthesia, Epidural","Opioid","Labor Pain",[1540,1516],"Fentanyl",{"trials":1542,"activeCount":100},[],{"intervention":1544,"totalTrials":134,"cells":1545},"benzodiazepines",{"EARLY_PHASE1":1546,"PHASE1":1548,"PHASE2":1550,"PHASE3":1552,"PHASE4":1554,"NA":1569},{"trials":1547,"activeCount":100},[],{"trials":1549,"activeCount":100},[],{"trials":1551,"activeCount":100},[],{"trials":1553,"activeCount":100},[],{"trials":1555,"activeCount":100},[1556],{"nctId":1557,"briefTitle":1558,"status":658,"phases":1559,"primaryCompletion":1560,"completion":1561,"start":1562,"enrollment":1563,"conditions":1564,"interventions":1567},"NCT03029676","The Assessment of POCD After TURBT Under Spinal Anesthesia",[91],"2017-12-31","2018-06-30","2017-01-01",200,[1565,1566],"Bladder Tumor","Postoperative Cognitive Dysfunction",[1544,1568],"opioid",{"trials":1570,"activeCount":100},[],{"intervention":1568,"totalTrials":134,"cells":1572},{"EARLY_PHASE1":1573,"PHASE1":1575,"PHASE2":1577,"PHASE3":1579,"PHASE4":1581,"NA":1587},{"trials":1574,"activeCount":100},[],{"trials":1576,"activeCount":100},[],{"trials":1578,"activeCount":100},[],{"trials":1580,"activeCount":100},[],{"trials":1582,"activeCount":100},[1583],{"nctId":1557,"briefTitle":1558,"status":658,"phases":1584,"primaryCompletion":1560,"completion":1561,"start":1562,"enrollment":1563,"conditions":1585,"interventions":1586},[91],[1565,1566],[1544,1568],{"trials":1588,"activeCount":100},[],{"intervention":133,"totalTrials":134,"cells":1590},{"EARLY_PHASE1":1591,"PHASE1":1593,"PHASE2":1595,"PHASE3":1597,"PHASE4":1599,"NA":1605},{"trials":1592,"activeCount":100},[],{"trials":1594,"activeCount":100},[],{"trials":1596,"activeCount":100},[],{"trials":1598,"activeCount":100},[],{"trials":1600,"activeCount":100},[1601],{"nctId":122,"briefTitle":123,"status":124,"phases":1602,"primaryCompletion":126,"completion":126,"start":127,"enrollment":128,"conditions":1603,"interventions":1604},[91],[130,118,119,116,131],[133,95],{"trials":1606,"activeCount":100},[],{"intervention":1608,"totalTrials":134,"cells":1609},"Empagliflozin 10 MG",{"EARLY_PHASE1":1610,"PHASE1":1612,"PHASE2":1614,"PHASE3":1616,"PHASE4":1630,"NA":1632},{"trials":1611,"activeCount":100},[],{"trials":1613,"activeCount":100},[],{"trials":1615,"activeCount":100},[],{"trials":1617,"activeCount":100},[1618],{"nctId":1619,"briefTitle":1620,"status":658,"phases":1621,"primaryCompletion":1622,"completion":1623,"start":1624,"enrollment":1625,"conditions":1626,"interventions":1628},"NCT05776043","Empagliflozin and Dapagliflozin in Patients Hospitalized for Acute Decompensated Heart Failure",[90],"2024-09-30","2025-12-31","2022-03-15",1364,[1627],"Acute Decompensated Heart Failure",[1608,1629],"Dapagliflozin 10 MG",{"trials":1631,"activeCount":100},[],{"trials":1633,"activeCount":100},[],{"intervention":1629,"totalTrials":134,"cells":1635},{"EARLY_PHASE1":1636,"PHASE1":1638,"PHASE2":1640,"PHASE3":1642,"PHASE4":1648,"NA":1650},{"trials":1637,"activeCount":100},[],{"trials":1639,"activeCount":100},[],{"trials":1641,"activeCount":100},[],{"trials":1643,"activeCount":100},[1644],{"nctId":1619,"briefTitle":1620,"status":658,"phases":1645,"primaryCompletion":1622,"completion":1623,"start":1624,"enrollment":1625,"conditions":1646,"interventions":1647},[90],[1627],[1608,1629],{"trials":1649,"activeCount":100},[],{"trials":1651,"activeCount":100},[],{"intervention":1653,"totalTrials":134,"cells":1654},"Human fecal microbiota, MBiotix HBI",{"EARLY_PHASE1":1655,"PHASE1":1657,"PHASE2":1659,"PHASE3":1661,"PHASE4":1675,"NA":1677},{"trials":1656,"activeCount":100},[],{"trials":1658,"activeCount":100},[],{"trials":1660,"activeCount":100},[],{"trials":1662,"activeCount":100},[1663],{"nctId":1664,"briefTitle":1665,"status":658,"phases":1666,"primaryCompletion":1667,"completion":1668,"start":1669,"enrollment":1670,"conditions":1671,"interventions":1673},"NCT04824222","The Impact of Fecal Microbiota Transplantation as an Immunomodulation on the Risk Reduction of COVID-19 Disease Progression With Escalating Cytokine Storm and Inflammatory Parameters",[90],"2022-07","2022-12","2021-04",366,[1672],"Covid19",[1653,1674],"SOC",{"trials":1676,"activeCount":100},[],{"trials":1678,"activeCount":100},[],{"intervention":1674,"totalTrials":134,"cells":1680},{"EARLY_PHASE1":1681,"PHASE1":1683,"PHASE2":1685,"PHASE3":1687,"PHASE4":1693,"NA":1695},{"trials":1682,"activeCount":100},[],{"trials":1684,"activeCount":100},[],{"trials":1686,"activeCount":100},[],{"trials":1688,"activeCount":100},[1689],{"nctId":1664,"briefTitle":1665,"status":658,"phases":1690,"primaryCompletion":1667,"completion":1668,"start":1669,"enrollment":1670,"conditions":1691,"interventions":1692},[90],[1672],[1653,1674],{"trials":1694,"activeCount":100},[],{"trials":1696,"activeCount":100},[],{"intervention":1698,"totalTrials":134,"cells":1699},"etanercept",{"EARLY_PHASE1":1700,"PHASE1":1702,"PHASE2":1704,"PHASE3":1715,"PHASE4":1717,"NA":1719},{"trials":1701,"activeCount":100},[],{"trials":1703,"activeCount":100},[],{"trials":1705,"activeCount":100},[1706],{"nctId":1707,"briefTitle":1708,"status":124,"phases":1709,"primaryCompletion":1710,"completion":662,"start":1711,"enrollment":498,"conditions":1712,"interventions":1714},"NCT01731457","Limitation of Ischemic Injury of a Kidney Stored in Machine Perfusion in Hypothermia - Evaluation of the Impact on Kidney Allograft Function",[89],"2014-02","2011-04",[1713],"Transplanted Kidney Ischemia Reperfusion Injury",[1698],{"trials":1716,"activeCount":100},[],{"trials":1718,"activeCount":100},[],{"trials":1720,"activeCount":100},[],{"intervention":1722,"totalTrials":134,"cells":1723},"Phenofibrate",{"EARLY_PHASE1":1724,"PHASE1":1726,"PHASE2":1728,"PHASE3":1739,"PHASE4":1741,"NA":1743},{"trials":1725,"activeCount":100},[],{"trials":1727,"activeCount":100},[],{"trials":1729,"activeCount":100},[1730],{"nctId":1731,"briefTitle":1732,"status":658,"phases":1733,"primaryCompletion":1734,"completion":1734,"start":1735,"enrollment":1736,"conditions":1737,"interventions":1738},"NCT05909800","Prolonged Remission Induced by Phenofibrate in Children Newly Diagnosed With Type 1 Diabetes.",[89],"2024-07","2022-09-29",102,[640],[1722],{"trials":1740,"activeCount":100},[],{"trials":1742,"activeCount":100},[],{"trials":1744,"activeCount":100},[],{"intervention":1746,"totalTrials":134,"cells":1747},"Autologous ADSC",{"EARLY_PHASE1":1748,"PHASE1":1750,"PHASE2":1752,"PHASE3":1767,"PHASE4":1769,"NA":1771},{"trials":1749,"activeCount":100},[],{"trials":1751,"activeCount":100},[],{"trials":1753,"activeCount":100},[1754],{"nctId":1755,"briefTitle":1756,"status":124,"phases":1757,"primaryCompletion":1758,"completion":1758,"start":1759,"enrollment":227,"conditions":1760,"interventions":1766},"NCT03887208","Therapy of Scars and Cutis Laxa With Autologous Adipose Derived Mesenchymal Stem Cells",[88,89],"2020-01-18","2018-01-31",[1761,1762,1763,1764,1765],"Skin","Scar","Cutis Laxa","Keloid","Cicatrix",[1746],{"trials":1768,"activeCount":100},[],{"trials":1770,"activeCount":100},[],{"trials":1772,"activeCount":100},[],{"intervention":1774,"totalTrials":134,"cells":1775},"Fecal Microbiota Transfer provided by Human Biome Institute",{"EARLY_PHASE1":1776,"PHASE1":1778,"PHASE2":1780,"PHASE3":1791,"PHASE4":1793,"NA":1795},{"trials":1777,"activeCount":100},[],{"trials":1779,"activeCount":100},[],{"trials":1781,"activeCount":100},[1782],{"nctId":1783,"briefTitle":1784,"status":124,"phases":1785,"primaryCompletion":1786,"completion":1786,"start":1787,"enrollment":1070,"conditions":1788,"interventions":1790},"NCT05204641","Effect of Fecal Microbiota Transfer on Progression of Parkinson Disease",[89],"2024-10-08","2022-01-04",[1789],"Parkinson Disease",[1774],{"trials":1792,"activeCount":100},[],{"trials":1794,"activeCount":100},[],{"trials":1796,"activeCount":100},[],{"intervention":1798,"totalTrials":134,"cells":1799},"Application of allogeneic ADSC stem cells in fibrin gel",{"EARLY_PHASE1":1800,"PHASE1":1802,"PHASE2":1804,"PHASE3":1816,"PHASE4":1818,"NA":1820},{"trials":1801,"activeCount":100},[],{"trials":1803,"activeCount":100},[],{"trials":1805,"activeCount":100},[1806],{"nctId":1807,"briefTitle":1808,"status":124,"phases":1809,"primaryCompletion":1810,"completion":1811,"start":1812,"enrollment":1813,"conditions":1814,"interventions":1815},"NCT03865394","Treatment of Chronic Wounds in Diabetic Foot Syndrome With Allogeneic Adipose Derived Mesenchymal Stem Cells",[88,89],"2021-03-31","2021-09-30","2019-07-01",46,[400],[1798],{"trials":1817,"activeCount":100},[],{"trials":1819,"activeCount":100},[],{"trials":1821,"activeCount":100},[],{"intervention":1823,"totalTrials":134,"cells":1824},"Intra-articular injection of ADMSC",{"EARLY_PHASE1":1825,"PHASE1":1827,"PHASE2":1829,"PHASE3":1843,"PHASE4":1845,"NA":1847},{"trials":1826,"activeCount":100},[],{"trials":1828,"activeCount":100},[],{"trials":1830,"activeCount":100},[1831],{"nctId":1832,"briefTitle":1833,"status":658,"phases":1834,"primaryCompletion":1835,"completion":1836,"start":1837,"enrollment":227,"conditions":1838,"interventions":1842},"NCT03869229","Adipose-derived Mesenchymal Stem Cells in Osteoarthritis",[88,89],"2020-03-01","2022-03-20","2019-04-05",[24,1839,1840,1841],"Hip Osteoarthritis","Glenohumeral Osteoarthritis","Osteoarthritis",[1823],{"trials":1844,"activeCount":100},[],{"trials":1846,"activeCount":100},[],{"trials":1848,"activeCount":100},[],{"intervention":1850,"totalTrials":134,"cells":1851},"Low-dose aspirin",{"EARLY_PHASE1":1852,"PHASE1":1854,"PHASE2":1856,"PHASE3":1867,"PHASE4":1869,"NA":1871},{"trials":1853,"activeCount":100},[],{"trials":1855,"activeCount":100},[],{"trials":1857,"activeCount":100},[1858],{"nctId":1859,"briefTitle":1860,"status":658,"phases":1861,"primaryCompletion":1862,"completion":1862,"start":1863,"enrollment":439,"conditions":1864,"interventions":1866},"NCT06254391","Aspirin Dose Comparison in Elderly PCI Patients: 30mg vs. 75mg in Acute Coronary Syndrome",[89],"2025-07","2023-07-03",[847,1865],"Acute Coronary Syndrome",[1850],{"trials":1868,"activeCount":100},[],{"trials":1870,"activeCount":100},[],{"trials":1872,"activeCount":100},[],{"intervention":1874,"totalTrials":134,"cells":1875},"Intraarticular injection of WJMSC",{"EARLY_PHASE1":1876,"PHASE1":1878,"PHASE2":1880,"PHASE3":1890,"PHASE4":1892,"NA":1894},{"trials":1877,"activeCount":100},[],{"trials":1879,"activeCount":100},[],{"trials":1881,"activeCount":100},[1882],{"nctId":1883,"briefTitle":1884,"status":658,"phases":1885,"primaryCompletion":1886,"completion":1887,"start":1189,"enrollment":227,"conditions":1888,"interventions":1889},"NCT03866330","Wharton's Jelly-derived Mesenchymal Stem Cells in Osteoarthritis",[88,89],"2019-12","2022-03-01",[1841,1839,24,1840],[1874],{"trials":1891,"activeCount":100},[],{"trials":1893,"activeCount":100},[],{"trials":1895,"activeCount":100},[],{"intervention":1897,"totalTrials":134,"cells":1898},"Ketamine",{"EARLY_PHASE1":1899,"PHASE1":1901,"PHASE2":1914,"PHASE3":1916,"PHASE4":1918,"NA":1920},{"trials":1900,"activeCount":100},[],{"trials":1902,"activeCount":100},[1903],{"nctId":1904,"briefTitle":1905,"status":658,"phases":1906,"primaryCompletion":1907,"completion":1908,"start":651,"enrollment":845,"conditions":1909,"interventions":1912},"NCT04409665","The Use of Sedation Drugs in the Procedure of Administering Surfactant Without Intubation (LISA\u002FMIST)",[88],"2022-03-31","2022-04-30",[1910,1911],"Neonatal Respiratory Distress Syndrome","Gestational Age Conditions",[1897,1913],"Glucose",{"trials":1915,"activeCount":100},[],{"trials":1917,"activeCount":100},[],{"trials":1919,"activeCount":100},[],{"trials":1921,"activeCount":100},[],{"intervention":1913,"totalTrials":134,"cells":1923},{"EARLY_PHASE1":1924,"PHASE1":1926,"PHASE2":1932,"PHASE3":1934,"PHASE4":1936,"NA":1938},{"trials":1925,"activeCount":100},[],{"trials":1927,"activeCount":100},[1928],{"nctId":1904,"briefTitle":1905,"status":658,"phases":1929,"primaryCompletion":1907,"completion":1908,"start":651,"enrollment":845,"conditions":1930,"interventions":1931},[88],[1910,1911],[1897,1913],{"trials":1933,"activeCount":100},[],{"trials":1935,"activeCount":100},[],{"trials":1937,"activeCount":100},[],{"trials":1939,"activeCount":100},[],{"intervention":1941,"totalTrials":134,"cells":1942},"Gelatin Tannate",{"EARLY_PHASE1":1943,"PHASE1":1945,"PHASE2":1956,"PHASE3":1958,"PHASE4":1960,"NA":1962},{"trials":1944,"activeCount":100},[],{"trials":1946,"activeCount":100},[1947],{"nctId":1948,"briefTitle":1949,"status":124,"phases":1950,"primaryCompletion":1951,"completion":1951,"start":1952,"enrollment":652,"conditions":1953,"interventions":1955},"NCT02280759","Efficacy of Gelatin Tannate in Treatment Acute Gastroenteritis in Children.",[88],"2017-06-10","2014-11",[1954],"Acute Gastroenteritis",[1941],{"trials":1957,"activeCount":100},[],{"trials":1959,"activeCount":100},[],{"trials":1961,"activeCount":100},[],{"trials":1963,"activeCount":100},[],{"intervention":1965,"totalTrials":134,"cells":1966},"Toothpaste including mustard extract",{"EARLY_PHASE1":1967,"PHASE1":1980,"PHASE2":1982,"PHASE3":1984,"PHASE4":1986,"NA":1988},{"trials":1968,"activeCount":100},[1969],{"nctId":1970,"briefTitle":1971,"status":124,"phases":1972,"primaryCompletion":1484,"completion":1973,"start":1974,"enrollment":1975,"conditions":1976,"interventions":1979},"NCT06908265","Clinical Evaluation of the Antibacterial Activity of Thioglycosides Extracted from White Mustard - Bamberka in Oral Hygiene. Evaluation of Periodontal Parameters and Oral Microbiota in Patients.",[87],"2017-01","2015-03",113,[1977,1978],"Gingival and Periodontal Disease","Caries, Dental",[1965],{"trials":1981,"activeCount":100},[],{"trials":1983,"activeCount":100},[],{"trials":1985,"activeCount":100},[],{"trials":1987,"activeCount":100},[],{"trials":1989,"activeCount":100},[],{"intervention":1991,"totalTrials":96,"cells":1992},"Fecal microbiota transplantation",{"EARLY_PHASE1":1993,"PHASE1":1995,"PHASE2":1997,"PHASE3":1999,"PHASE4":2001,"NA":2003},{"trials":1994,"activeCount":100},[],{"trials":1996,"activeCount":100},[],{"trials":1998,"activeCount":100},[],{"trials":2000,"activeCount":100},[],{"trials":2002,"activeCount":100},[],{"trials":2004,"activeCount":100},[2005,2015],{"nctId":2006,"briefTitle":2007,"status":658,"phases":2008,"primaryCompletion":2009,"completion":2010,"start":2011,"enrollment":791,"conditions":2012,"interventions":2014},"NCT02461199","Stool Transplantation to Reduce Antibiotic Resistance Transmission",[],"2017-02","2017-09","2015-02",[2013],"Blood Disorders",[1991],{"nctId":2016,"briefTitle":2017,"status":658,"phases":2018,"primaryCompletion":2019,"completion":2019,"start":2020,"enrollment":2021,"conditions":2022,"interventions":2024},"NCT06333405","Fecal Microbiota Transplantation (FMT) as a Prophylaxis of Necrotizing Enterocolitis (NEC) - Clinical Study",[92],"2025-01-31","2024-05-01",20,[2023],"Necrotizing Enterocolitis",[2025],"Fecal Microbiota Transplantation",{"intervention":2027,"totalTrials":96,"cells":2028},"Morphine PCA pump",{"EARLY_PHASE1":2029,"PHASE1":2031,"PHASE2":2033,"PHASE3":2035,"PHASE4":2037,"NA":2039},{"trials":2030,"activeCount":100},[],{"trials":2032,"activeCount":100},[],{"trials":2034,"activeCount":100},[],{"trials":2036,"activeCount":100},[],{"trials":2038,"activeCount":100},[],{"trials":2040,"activeCount":100},[2041,2052],{"nctId":2042,"briefTitle":2043,"status":124,"phases":2044,"primaryCompletion":2045,"completion":2046,"start":2047,"enrollment":2048,"conditions":2049,"interventions":2051},"NCT03874091","Clinical Effectiveness of Erector Spinae Plane Block in Peri-operative Analgesia for Laparoscopic Nephrectomy\u002FNephron Sparing Surgery (NSS)\u002FHynes-Anderson Procedures.",[92],"2020-09-07","2021-10-01","2019-01-15",62,[2050],"Erector Spinae Plane Block",[2027],{"nctId":2053,"briefTitle":2054,"status":658,"phases":2055,"primaryCompletion":2056,"completion":1835,"start":1189,"enrollment":2057,"conditions":2058,"interventions":2059},"NCT03887260","Clinical Effectiveness of Erector Spinae Plane Block in Peri-operative Analgesia for Nephrectomy\u002FNephron Sparing Surgery(NSS) Performed Via Lumbotomy",[92],"2019-07-20",42,[2050],[2027,1540],{"intervention":1540,"totalTrials":96,"cells":2061},{"EARLY_PHASE1":2062,"PHASE1":2064,"PHASE2":2066,"PHASE3":2068,"PHASE4":2070,"NA":2076},{"trials":2063,"activeCount":100},[],{"trials":2065,"activeCount":100},[],{"trials":2067,"activeCount":100},[],{"trials":2069,"activeCount":100},[],{"trials":2071,"activeCount":100},[2072],{"nctId":1529,"briefTitle":1530,"status":658,"phases":2073,"primaryCompletion":1532,"completion":1532,"start":1533,"enrollment":1534,"conditions":2074,"interventions":2075},[91],[1536,1537,1538],[1540,1516],{"trials":2077,"activeCount":100},[2078],{"nctId":2053,"briefTitle":2054,"status":658,"phases":2079,"primaryCompletion":2056,"completion":1835,"start":1189,"enrollment":2057,"conditions":2080,"interventions":2081},[92],[2050],[2027,1540],{"intervention":2083,"totalTrials":134,"cells":2084},"Direct Acting Antivirals",{"EARLY_PHASE1":2085,"PHASE1":2087,"PHASE2":2089,"PHASE3":2091,"PHASE4":2093,"NA":2095},{"trials":2086,"activeCount":100},[],{"trials":2088,"activeCount":100},[],{"trials":2090,"activeCount":100},[],{"trials":2092,"activeCount":100},[],{"trials":2094,"activeCount":100},[],{"trials":2096,"activeCount":100},[2097],{"nctId":2098,"briefTitle":2099,"status":658,"phases":2100,"primaryCompletion":2101,"completion":1668,"start":2102,"enrollment":227,"conditions":2103,"interventions":2109},"NCT05376943","Possible Differences in HCC Course Depending on DAA Treatment",[],"2022-10","2022-05-10",[2104,2105,2106,2107,2108,30],"Carcinoma, Hepatocellular","Hepatitis C Virus Infection, Response to Therapy of","Drug Effect","Drug Side Effect","Hepatitis C, Chronic",[2083],{"intervention":2111,"totalTrials":134,"cells":2112},"Diphtheria booster vaccination",{"EARLY_PHASE1":2113,"PHASE1":2115,"PHASE2":2117,"PHASE3":2119,"PHASE4":2121,"NA":2123},{"trials":2114,"activeCount":100},[],{"trials":2116,"activeCount":100},[],{"trials":2118,"activeCount":100},[],{"trials":2120,"activeCount":100},[],{"trials":2122,"activeCount":100},[],{"trials":2124,"activeCount":100},[2125],{"nctId":2126,"briefTitle":2127,"status":124,"phases":2128,"primaryCompletion":2129,"completion":2129,"start":2130,"enrollment":1813,"conditions":2131,"interventions":2134},"NCT03998215","Diphtheria Vaccination in Adolescents With Inflammatory Bowel Disease",[92],"2015-01-01","2012-12-01",[2132,2133],"Diphtheria","Inflammatory Bowel Diseases",[2111],{"intervention":2136,"totalTrials":134,"cells":2137},"Envarsus",{"EARLY_PHASE1":2138,"PHASE1":2140,"PHASE2":2142,"PHASE3":2144,"PHASE4":2146,"NA":2148},{"trials":2139,"activeCount":100},[],{"trials":2141,"activeCount":100},[],{"trials":2143,"activeCount":100},[],{"trials":2145,"activeCount":100},[],{"trials":2147,"activeCount":100},[],{"trials":2149,"activeCount":100},[2150],{"nctId":2151,"briefTitle":2152,"status":658,"phases":2153,"primaryCompletion":2154,"completion":2154,"start":2155,"enrollment":1563,"conditions":2156,"interventions":2158},"NCT03603548","Comparison of Safety and Efficacy of Two Variants of Prolonged - Released Tacrolimus (Advagraf vs. Envarsus ) in Patients After Liver Transplantation : Single Center Randomised Control Trial",[92],"2023-07-09","2018-07-09",[2157,274],"Liver Transplant Rejection",[2136,2159],"Advagraf",{"intervention":2159,"totalTrials":134,"cells":2161},{"EARLY_PHASE1":2162,"PHASE1":2164,"PHASE2":2166,"PHASE3":2168,"PHASE4":2170,"NA":2172},{"trials":2163,"activeCount":100},[],{"trials":2165,"activeCount":100},[],{"trials":2167,"activeCount":100},[],{"trials":2169,"activeCount":100},[],{"trials":2171,"activeCount":100},[],{"trials":2173,"activeCount":100},[2174],{"nctId":2151,"briefTitle":2152,"status":658,"phases":2175,"primaryCompletion":2154,"completion":2154,"start":2155,"enrollment":1563,"conditions":2176,"interventions":2177},[92],[2157,274],[2136,2159],{"intervention":2179,"totalTrials":134,"cells":2180},"Methylprednisolone",{"EARLY_PHASE1":2181,"PHASE1":2183,"PHASE2":2185,"PHASE3":2187,"PHASE4":2189,"NA":2191},{"trials":2182,"activeCount":100},[],{"trials":2184,"activeCount":100},[],{"trials":2186,"activeCount":100},[],{"trials":2188,"activeCount":100},[],{"trials":2190,"activeCount":100},[],{"trials":2192,"activeCount":100},[2193],{"nctId":2194,"briefTitle":2195,"status":124,"phases":2196,"primaryCompletion":2197,"completion":2197,"start":2198,"enrollment":2199,"conditions":2200,"interventions":2203},"NCT03590080","Impact of Intravenous Methylprednisolone Treatment on Blood Pressure",[],"2015-12-30","2011-01-01",32,[1014,1015,2201,2202,15],"Hypertension","Blood Pressure",[2179],{"intervention":2205,"totalTrials":134,"cells":2206},"Prophylactic administration of antithyroid drugs before iodinated contrast media exposure",{"EARLY_PHASE1":2207,"PHASE1":2209,"PHASE2":2211,"PHASE3":2213,"PHASE4":2215,"NA":2217},{"trials":2208,"activeCount":100},[],{"trials":2210,"activeCount":100},[],{"trials":2212,"activeCount":100},[],{"trials":2214,"activeCount":100},[],{"trials":2216,"activeCount":100},[],{"trials":2218,"activeCount":100},[2219],{"nctId":2220,"briefTitle":2221,"status":124,"phases":2222,"primaryCompletion":2223,"completion":2223,"start":2224,"enrollment":2225,"conditions":2226,"interventions":2232},"NCT04304794","Iodinated Contrast Media Induced Hyperthyroidism",[],"2020-02-20","2015-01-02",36,[2227,2228,2229,2230,2231],"Hyperthyroidism\u002FThyrotoxicosis","Hyperthyroidism; Goiter","Iodine Induced Thyrotoxicosis","Contrast Media Adverse Reaction","Thyrotoxicosis of Other Specified Origin",[2205],{"intervention":2234,"totalTrials":134,"cells":2235},"Intravenous Methylprednisolone",{"EARLY_PHASE1":2236,"PHASE1":2238,"PHASE2":2240,"PHASE3":2242,"PHASE4":2244,"NA":2246},{"trials":2237,"activeCount":100},[],{"trials":2239,"activeCount":100},[],{"trials":2241,"activeCount":100},[],{"trials":2243,"activeCount":100},[],{"trials":2245,"activeCount":100},[],{"trials":2247,"activeCount":100},[2248],{"nctId":2249,"briefTitle":2250,"status":124,"phases":2251,"primaryCompletion":2223,"completion":2223,"start":2198,"enrollment":439,"conditions":2252,"interventions":2254},"NCT04391439","Heart Rhythm After Intravenous Methylprednisolone Administration",[],[1014,1015,2253,2201,2202,15],"Heart Rhythm Disorder",[2234],{"intervention":2256,"totalTrials":134,"cells":2257},"Vaccination against cholera",{"EARLY_PHASE1":2258,"PHASE1":2260,"PHASE2":2262,"PHASE3":2264,"PHASE4":2266,"NA":2268},{"trials":2259,"activeCount":100},[],{"trials":2261,"activeCount":100},[],{"trials":2263,"activeCount":100},[],{"trials":2265,"activeCount":100},[],{"trials":2267,"activeCount":100},[],{"trials":2269,"activeCount":100},[2270],{"nctId":2271,"briefTitle":2272,"status":124,"phases":2273,"primaryCompletion":2274,"completion":2275,"start":2276,"enrollment":2277,"conditions":2278,"interventions":2280},"NCT03998449","Immunogenicity of Cholera Vaccine in Children With IBD",[92],"2020-04-01","2020-05-01","2017-08-30",80,[2279,2133],"Cholera",[2256],{"intervention":2282,"totalTrials":134,"cells":2283},"Tocilizumab",{"EARLY_PHASE1":2284,"PHASE1":2286,"PHASE2":2288,"PHASE3":2290,"PHASE4":2292,"NA":2294},{"trials":2285,"activeCount":100},[],{"trials":2287,"activeCount":100},[],{"trials":2289,"activeCount":100},[],{"trials":2291,"activeCount":100},[],{"trials":2293,"activeCount":100},[],{"trials":2295,"activeCount":100},[2296],{"nctId":2297,"briefTitle":2298,"status":658,"phases":2299,"primaryCompletion":2300,"completion":2301,"start":2302,"enrollment":2303,"conditions":2304,"interventions":2308},"NCT06367517","Tocilizumab in Corticosteroid-Resistant Graves' Orbitopathy (Thyroid Eye Disease)",[],"2025-05-20","2026-05-20","2021-05-20",30,[2305,2306,2307],"Orbitopathy, Graves","Thyroid Eye Disease","Ophthalmopathy",[2282],{"intervention":2310,"totalTrials":134,"cells":2311},"Ephedrine",{"EARLY_PHASE1":2312,"PHASE1":2314,"PHASE2":2316,"PHASE3":2318,"PHASE4":2320,"NA":2322},{"trials":2313,"activeCount":100},[],{"trials":2315,"activeCount":100},[],{"trials":2317,"activeCount":100},[],{"trials":2319,"activeCount":100},[],{"trials":2321,"activeCount":100},[],{"trials":2323,"activeCount":100},[2324],{"nctId":2325,"briefTitle":2326,"status":124,"phases":2327,"primaryCompletion":2328,"completion":2329,"start":2330,"enrollment":791,"conditions":2331,"interventions":2336},"NCT03858465","Comparison of Phenylephrine and Ephedrine in the Treatment of Hemodynamic Disorders After Spinal Anesthesia in the Elderly",[92],"2019-02-24","2023-02-01","2019-02-01",[2332,2333,2334,2335],"Hip Fractures","Elderly Patients","Spinal Anesthesia","Lower Limb Surgery",[2310,2337],"Phenylephrine",{"intervention":2337,"totalTrials":134,"cells":2339},{"EARLY_PHASE1":2340,"PHASE1":2342,"PHASE2":2344,"PHASE3":2346,"PHASE4":2348,"NA":2350},{"trials":2341,"activeCount":100},[],{"trials":2343,"activeCount":100},[],{"trials":2345,"activeCount":100},[],{"trials":2347,"activeCount":100},[],{"trials":2349,"activeCount":100},[],{"trials":2351,"activeCount":100},[2352],{"nctId":2325,"briefTitle":2326,"status":124,"phases":2353,"primaryCompletion":2328,"completion":2329,"start":2330,"enrollment":791,"conditions":2354,"interventions":2355},[92],[2332,2333,2334,2335],[2310,2337]]